BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 426503)

  • 1. Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function.
    Humbert G; Spyker DA; Fillastre JP; Leroy A
    Antimicrob Agents Chemother; 1979 Jan; 15(1):28-33. PubMed ID: 426503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of parenteral amoxycillin, biliary excretion and effect of renal failure.
    Chelvan P; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1979 Mar; 5(2):232-3. PubMed ID: 429253
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
    Blum RA; Kohli RK; Harrison NJ; Schentag JJ
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of intravenous amoxicillin in patients on long-term dialysis.
    Francke EL; Appel GB; Neu HC
    Clin Pharmacol Ther; 1979 Jul; 26(1):31-5. PubMed ID: 445959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.
    Spyker DA; Rugloski RJ; Vann RL; O'Brien WM
    Antimicrob Agents Chemother; 1977 Jan; 11(1):132-41. PubMed ID: 836010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.
    Spyker DA; Thomas BL; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1978 Aug; 14(2):172-7. PubMed ID: 697345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Ozawa Y
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K
    Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.
    Gordon C; Regamey C; Kirby WM
    Antimicrob Agents Chemother; 1972 Jun; 1(6):504-7. PubMed ID: 4680813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human intravenous and intramuscular pharmacokinetics of amoxicillin.
    Mastrandrea V; Ripa S; La Rosa F; Tarsi R
    Int J Clin Pharmacol Res; 1984; 4(3):209-12. PubMed ID: 6490239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis.
    Spyker DA; Gober LL; Scheld WM; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1982 Feb; 21(2):278-81. PubMed ID: 7073265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous amoxicillin in pediatric patients.
    Rudoy RC; Goto N; Pettit D; Uemura H
    Antimicrob Agents Chemother; 1979 Apr; 15(4):628-9. PubMed ID: 464594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxycillin: pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure.
    Lawson DH; Henderson AK; McGeachy RR
    Postgrad Med J; 1974 Aug; 50(586):500-3. PubMed ID: 4618910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin.
    Horber FF; Frey FJ; Descoeudres C; Murray AT; Reubi FC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):614-9. PubMed ID: 3707111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.
    Pechère JC; Pechère MM; Dugal R
    Antimicrob Agents Chemother; 1976 May; 9(5):761-5. PubMed ID: 986124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choice of amoxycilin dosage in impaired renal function (author's transl)].
    Dzúriková V; Simkovicová M; Fedelesová V; Dzúrik R
    Bratisl Lek Listy; 1978 Apr; 69(4):468-73. PubMed ID: 638809
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hemodialysis on the pharmacokinetics of amoxicillin/clavulanic acid combination.
    Slaughter RL; Kohli R; Brass C
    Ther Drug Monit; 1984; 6(4):424-7. PubMed ID: 6393464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.